Parathyroid hormone (PTH) regulates mineral metabolism and bone turnover by activating specific receptors located on osteoblastic and renal tubular cells and is fully functional as the N-terminal 1-34 fragment, PTH-(1-34). Previously, a "U-shaped" conformation with Nand C-terminal helices brought in close proximity by a turn has been postulated. The general acceptance of this hypothesis, despite limited experimental evidence, has altered the direction of the design of PTH-analogs. Examining the structure of human PTH-(1-34) under conditions that encompass the different environments the hormone may experience in the approach to and interaction with the G-protein-coupled receptor (including benign aqueous and saline solutions and in the presence of dodecylphosphocholine), we observe no evidence for a U-shape conformation or any tertiary structure. Instead, the N-and C-terminal helical domains, which vary in length and stability depending on the condi- 
Human parathyroid hormone (hPTH) 1 has been the object of numerous studies for many years now, owing to its crucial role in the regulation of extracellular calcium homeostasis (1) . More recently, we evidence a growing interest in PTH and PTHderived agonists as anabolic agents in bone remodeling and their promise as new drugs for the treatment of osteoporosis. It has been established that the 34 residues at the N terminus of the 84-amino acid protein, hPTH- , are sufficient for high affinity binding to the PTH receptor (a G-protein-coupled receptor) and retain PTH-like bone-related activities (2, 3) . Biological activity studies on hybrid peptides of PTH and the parathyroid hormone-related protein (PTHrP), which binds to and activates the same receptor, indicate a functional interaction between the 1-14 and 15-34 domains (4) .
On the basis of theoretical methods for secondary structure prediction, both the N and C termini of PTH-(1-34) are expected to be helical. Furthermore, the amphipathic character of the two putative helices has suggested helix-helix interactions resulting in a "U-shaped" tertiary structure with a hydrophobic core and outwardly facing hydrophilic residues (5) . Notably, only a low ␣-helical content could be identified for hPTH- in aqueous solution ([] r 222 ϭ Ϫ6800; average of literature values as reported by Willis (see Ref. 6) corresponding to approximately 8 residues in ␣-helix (see Ref. 7) ). Only upon addition of the structure inducing solvent trifluoroethanol (TFE), a helix content consistent with the two predicted helical segments was observed. Unfortunately, the majority of the NMRderived structures of hPTH- in TFE (8 -10) do not provide any evidence of long range interactions between the two helices. This has been attributed to the low dielectric constant (⑀ ϭ 26.7) of TFE, which could weaken hydrophobic interactions and therefore destabilize the alleged tertiary structure (11) .
Recently, new evidence emerging from the NMR study of hPTH- in aqueous solution in the presence of salts was interpreted in favor of the U-shape hypothesis (11) . However, the reported long range NOEs are limited only to the turn portion of the U-shape and do not include residues further toward the termini. Therefore, the experimental data do not define the relative topological arrangement of the helices; any helix-loop-helix conformation is consistent with the data. In addition, the conformational consequences of the experimental conditions employed, namely the pH and the high salt concentration, were not investigated. Highly questionable U-shape conformations have been reported for PTHrP analogs in the presence of TFE (12) (13) (14) .
Here, we report high resolution structures of hPTH-(1-34) in aqueous solution, investigating the effect of pH and salt concentration on secondary and tertiary structure (hPTH-(1-34) is equipotent to hPTH-(1-37) and displays identical affinity to the PTH/PTHrP receptor). In addition, we examined the peptide in the presence of dodecylphosphocholine (DPC) micelles. Micellar systems have often been used as an NMR-compatible model system for mimicking biological membranes (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) . A mem-* This work was supported in part by Grants R01-DK47940 (to M. R.) and GM54082 (to D. F. M.) from the National Institutes of Health. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
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brane-ligand interaction and membrane-induced conformation have been proposed as an operational pathway for the interaction between peptide hormones and their receptors (25) (26) (27) (28) .
The structural study utilizes experimental data both from circular dichroism (CD) and NMR spectroscopies, providing, respectively, an estimate of the helix content and the location of the ␣-helix, possibly including long range interactions determining a tertiary fold. The NMR study was coupled with a protocol of structure calculation that could assure adequate sampling of conformational space (metric matrix distance geometry, DG), followed by further refinement with extensive molecular dynamics (MD) simulations incorporating explicit solvent. The high resolution conformational preferences of hPTH-(1-34) in aqueous and saline solutions and in the presence of a membrane mimetic is required to advance the structureactivity relationship of the hormone and provide a reliable template for rational design of non-peptidic PTH-mimetic agonists.
EXPERIMENTAL PROCEDURES
The synthesis and purification of the peptide followed published procedures (29) .
Circular Dichroism--Spectra were recorded using an Aviv CD spectrometer (model 62 DS), interfaced with a personal computer. Spectra were acquired on 30 The complete amino acid spin systems were identified from double quantum filtered correlation spectroscopy (32) and TOCSY (33, 34) spectra. NOESY (35, 36) and ROESY (37) experiments with mixing times of 125-350 ms were employed for the sequential assignment. All the experiments were recorded in the phase-sensitive mode according to the method detailed by States et al. (38) . The TOCSY utilized a MLEV-17 sequence to realize mixing times of 40 -70 ms with a spin-lock field of 10,000 Hz. In the ROESY experiment, a spin-lock field of 2500 Hz was realized by a continuous wave pulse. Suppression of the solvent signal was achieved by continuous wave presaturation at low power level during the relaxation delay (1.5-2 s), and for NOESY experiments also during the mixing time. The typical spectral width was 6500 Hz in both dimensions, with 4096 data points in t 2 and 512-640 data points in t 1 and with 32-128 scans at each increment. Forward linear prediction to 1024 points was applied to the incremented dimension; both dimensions were multiplied by Gaussian or shifted squared sine bell apodization functions, prior to Fourier transformation.
Back-calculation of NOESY spectra utilized the matrix doubling method within the Felix program. The cutoff distance was set at 8 Å, the correlation time to 1 ns, and the smallest back-calculated intensity to be saved was set to 0.001, representing a 0.1% NOE enhancement.
Distance Geometry-NOESY spectra acquired at 285 K with a mixing time of 200 ms were utilized to measure cross-peak volumes for the two water samples, while a mixing time of 150 ms at 308 K was employed for the DPC sample. The volumes were converted to distances using the two-spin approximation and the cross-peaks between couples of aromatic protons of Trp 23 and between the two ␤ protons of Trp 23 (39) , was utilized to calculate an ensemble of structures fulfilling holonomic (constitutional) and experimental (proton-proton distances) restraints. The 100 starting structures were obtained by random sampling of the distances between the upper and lower bounds. They were first embedded in four dimensions and optimized versus the initial distance restraints (conjugate gradients) (40). This step was followed by distance-driven dynamics (DDD) (41, 42) , carried out at 500 K for 100 ps, and by slow cooling to 1 K. A new metrization reduced the resulting structures to three dimensions for the next optimization and DDD. The DDD procedure applies a simple square well potential on holonomic and experimental distances and an additional penalty term to maintain chirality and planarity, to generate the violation "energy" and calculate the forces.
The ensemble calculations consist of the DDD method in which the penalty expression for the experimental restraints (distances) and the subsequent force applied are generated from an ensemble average, following published procedures (43, 44) . The ensemble calculations utilized 10,000 steps of 20 fs at 500 K, followed by a slow reduction of the temperature to 1 K in 2500 steps.
Molecular Dynamics-MD simulations were performed with GRO-MACS (45), and interactive modeling was performed using Insight II (Biosym Technologies Inc., San Diego). Only the structures resulting from the study in water and in the presence of salts were examined. The starting structures for the simulations were chosen from the low energy structures obtained from DG as described under "Results." All atoms and the solvent were simulated explicitly. The peptide structure was placed in a rectangular box of H 2 O (46, 47), allowing at least 10 Å between the walls and the peptide and using three-dimensional periodic boundary condition. The charges of ionizable groups correspond to the pH of the NMR solution; no counter ions were included. A time step of 2.0 fs was employed. Neighbor lists for calculation of nonbonded interactions were updated every 20 steps within a radius of 10 Å. No switching function was utilized. The system was energy-minimized for 100 steps using steepest descent. Following this, 10 ps of MD at 300 K (48) with the peptide restrained to its original position with a force constant of 1000 kJ mol Ϫ1 nm Ϫ1 were carried out. Experimental distance restraints were then introduced with a force constant of 6000 kJ mol Ϫ1 nm Ϫ1 for 20 ps, and subsequently raised to 10,000 kJ mol Ϫ1 nm
Ϫ1
for the rest of the simulation (200 -400 ps). Structures were sampled every 0.5 ps. One iteration took approximately 2.7 s on one processor of a SGI Challenger (R8000, 150 MHz). The resulting trajectories were examined with analysis programs in the GROMACS package and home-written Fortran programs.
RESULTS
The helix content of hPTH-(1-34) based on CD spectra (given in Fig. 1 ) increases in the presence of phosphate buffer at pH Ն 6 (from 24% in benign water to 28% in buffer) and reaches a maximum of 54% in the presence of DPC micelles. Spectra acquired in the presence of phosphate or acetate buffer but at acidic pH are almost identical to the spectrum in benign H 2 O (data not shown). The solution containing phosphate buffer at pH ϭ 6 displays a small temperature dependence. A small decrease of helix content (indicated by the ellipticity at 222 nm) lated as an average of the 95 structures are 1.9 Å for residues 6 -10, 2.6 Å for residues 20 -27, and 8.7 Å (using only the backbone atoms) for the entire peptide, indicating the predominance of flexible over ordered structures in benign aqueous solution. The structural features consist of an irregular helix between residues 21 and 26 and a loop centered on residues 7-8. Extensive MD simulations (200 ps with explicit solvent) confirm that the irregular ␣-helical structure in the identified regions is energetically stable and consistent with the experimental NOEs. The average , dihedral angles from the simulation are reported in Table I .
NMR in H 2 O and Salts-The CSI values for ␣ protons in the presence of phosphate buffer and salts are similar to that observed in benign water solution (Fig. 2B) . The extent of the negative deviations in this case is significantly larger for both the C-and N-terminal helix. This qualitatively indicates a larger content/population of ␣-helix, as do the greater dispersion of chemical shifts and the larger number of medium range NOEs (Fig. 4) HN(iϩ4) (i ϭ 18, 21, 24 A total of 229 informative distance restraints were used in the DG calculations, of which 149 from inter-residue NOEs. The , values of the resulting 95 DG structures approach those of an ideal ␣-helix for residues 5-7 in the N terminus and 21-26 in the C terminus. The dihedral angle order parameters for , show convergence of the structures (values Ͼ 0.8) about residues 4, 5, 6, 10, and 22-26 (Fig. 4) . Pairwise r.m.s. deviation values are 0.92, 1.97, 0.76, and 6.4 Å for the heavy backbone atoms of residues 4 -7, 17-27, 22-26, and 1-34, respectively. The average of the DG structures results in no NOE violation greater than 0.15 Å. However, single structures displayed violations of 0.35 Å to H␣(i)-HN(iϩ1) sequential NOEs in different locations of the sequence. This is a clear indication that single structures cannot fulfill the experimental restraints produced by the coexistence of structured and unstructured peptide molecules equilibrating in solution. To address conformational averaging, ensemble calculations (44) were carried out.
A "minimum" ensemble of two structures, randomly chosen from the 95 DG structures, was utilized. In the ensemble approach (44), each structure must fulfill the constraints from the constitution (molecular connectivity), but only the ensemble average (average over the two structures) is required to fulfill the experimental distance restraints. Using the ensemble, the largest upper limit violation dropped to 0.06 Å. In Fig. 5 , a ribbon representation of the two structures illustrates the coexistence of ␣-helix (in gray) and extended structure at the C terminus of the molecule. Therefore assuming an equilibrium between only two conformations is sufficient to generate agreement between the calculated structures and experimental data.
To examine for the presence of tertiary structure, a plot of the distance between the N and C termini and the energy of the DG structures was carried out. The distances ranged between 10 to 45 Å, with no visible correlation between energy and distance; using the DG force field, based solely on connectivity and experimental distances, structures assuming a U-shape and "linear" conformation are equally favored. Representative structures of these extreme orientations of the two helical domains, linear and U-shaped (the angle between the axis of the two helices is approximately 55 degrees), were used as starting structures for extensive MD simulations. The aim of the MD simulations is to refine the local geometry in the presence of solvent, utilizing a full-atom representation force field, including Coulombic interactions and the LennardJones attractive forces, which are not considered in the DG calculations.
Both structures were found to be stable in the time frame examined by the simulations (400 ps). The ␣-helical domains were preserved with the , values adopting even more classical ␣-helix values. The carbonyl and HN groups align toward the axis of the helix producing hydrogen bonds that presumably stabilize the structure and act as a driving force toward the formation of the more classical ␣-helix. The average of , dihedral angles from the MD trajectories is reported in Table I .
Structures sampled every picosecond from the two MD simulations were analyzed with the program Procheck_NMR (52), to examine the "health" of the conformations with respect to allowed regions in the Ramachandran map, based on regular protein structures. For the U-shape and linear conformations, 90.6% and 89.8% of the residues, respectively, fall in regions of the Ramachandran map defined as "most favored" and "additionally favored." Only 4.5% and 2.9%, for the U-shape and linear, respectively, are in disallowed regions. This confirms 4 -14) . The well ordered structure is reflected by high order parameters for the and dihedral angles (Fig. 3) . Low values at residues 18 and 19 indicate flexibility in the central part of the molecule (importantly, there was no resonance overlap preventing the detection of NOEs in this region). A flexible domain in the center of the molecule allows a range of different orientations of the two well defined helices relative to each other. Consequently, the r.m.s. deviation value for the 34 amino acids of the peptide is very large (6.0 Å). The family of structures and the consequences of the flexible domain are indicated in Fig. 6 . The average angle between the two helical domains is 115 Ϯ 30°.
DISCUSSION
The NMR studies and relative DG/MD calculations presented in this work indicate that the conformation of hPTH-(1-34) in aqueous solution depends largely on the experimental conditions. In addition, the presence of conformational averaging fast on the NMR time scale must be considered to produce accurate and high resolution structures consistent with the experimental observations.
In benign aqueous solution, the peptide is mainly disordered. The CD data account for about eight helical residues, in agreement with much of the literature data (6). The only NMR evidence for the presence of ordered structure (indeed, an equilibrium between ordered and random conformations) is provided by a few weak NOEs, typical of ␣-helix. These NOEs are in general agreement with the structure of Lee and Russell (53) and with our CD data, and provide additional evidence for one loop of helix at the N terminus. Our results are in stark contrast with the structure presented by Barden and Kemp (54) . Despite very similar experimental conditions, their proposed conformation consists of two helical domains with a tertiary fold determined by a large number of long range interactions. These contrasting structures cannot be attributed to the difference at the C terminus (i.e. a free carboxylic acid used in this study versus a carboxamide used in their study). Importantly, the structure proposed by these authors is not consistent with the CD data. It is important to note that a significant overlap of NMR signals, particularly of the side chain resonances, are reported by these authors (54) that would make an unambiguous assignment of all of the NOEs listed in this publication particularly difficult. Additionally, the collapsing of the two helical domains to adopt a U-shape may arise from the utilization of in vacuo calculations for structure refinement. The observation of collapsed structures, particularly peptides, from the overemphasis of the non-bonded terms (i.e. Coulombic and van der Waals attraction) in the absence of explicit solvent has been addressed in the literature (55, 56) .
Concerning hPTH-(1-34) in high salt concentration, our NMR data provide no evidence of tertiary structure or any long range interaction deriving from a hydrophobic collapse of residues 15 and 23, despite careful examination of NOESY spectra collected with differing mixing times and temperatures. The molecule is far too flexible to prefer any definite secondary or tertiary fold. Two regions of the sequence appear to have a tendency to fold into a ␣-helix and account for the CD spectra (namely residues 6 -10 in the N terminus and residues 18 -29 in the C terminus), but they do not constitute stable, long-lived ␣-helices.
The difference between the conformation in H 2 O at pH 4.3 and in saline solution does not arise exclusively from the different ionic strength of the solution or the salt utilized. CD spectra in aqueous solutions containing 50 mM phosphate buffer at pH 4.6 or 50 mM acetate buffer at pH 4.9 (results not shown) give similar values of [] r 222 to that observed for hPTH-(1-34) in benign H 2 O solution (Ϫ6800 versus Ϫ6300). The average ellipticity values measured for solutions containing 50 mM phosphate buffer at pH 6 or 9, in the absence or presence of NaCl, are [] r 222 of Ϫ8000, accounting for about 10 residues in ␣-helix. The apparent discrepancy between the differences in the NMR spectra of the two solutions and the similarity of the CD spectra can be explained by averaging of the various conformational states in solution. Indeed, a good agreement between the NMR data and calculated structures for hPTH-(1-34) in water/ salts was achieved only upon considering an equilibrium between helical and extended conformations. The ensemble of two structures utilized in the ensemble calculations produced two conformations, each of them representative of 50% of the population and displaying shorter ␣-helical segments, located in different, alternating regions of the peptide. If the combination of the helical segments observed in the two conformations is considered, it is consistent with the distribution of NOEs, indicative of 17-24 residues in an ␣-helix (residues 3-5 to 12 and 16 -18 to 28 -31) , while the population of 50% of each conformation explains the 10 residues in ␣-helix calculated from the CD spectra.
Despite the similar medium range interactions observed here for hPTH-(1-34) and those reported for hPTH-(1-37) (11), the resulting conformations are drastically different. Indeed, the C-terminal helix is more stable in the presence of salt than in benign H 2 O and extends to include residues 16 -18, placing the hydrophobic side chains of amino acids Trp 23 and Leu 15 at a short distance, separated by only two loops of helix. The close proximity may induce a hydrophobic interaction that will contribute to stabilize the helix. The interaction between amino acids containing aromatic rings with hydrophobic residues has been reported to significantly stabilize helices, although usually spaced i, iϩ4 residues apart (57) . From the computational searching of conformational space, we find that the medium range NOEs between Leu 15 and Trp 23 are compatible with a large number of tertiary folds or topological arrangements of the two helical domains. This is a consequence of the flexibility of the central portion of the molecule producing a large variability of interhelical angles between the two helical domains. Two representative conformations, a linear and a U-shaped arrangement, representing the conformational extremes, were further examined by extensive MD simulations. During the MD simulations of the U-shaped conformation, the two helices (N-and C-terminal) are too far apart for interhelical contacts or justify a hydrophobic interaction as a stabilizing factor of the tertiary fold.
To further examine the putative U-shaped conformation, theoretical NOESY spectra were calculated using coordinates of a U-shaped conformation (as previously reported in Ref. 11) generated by molecular modeling. The back-calculation of NOEs from a structure is a powerful method for identification of conformations not consistent with the experimentally observed NOEs. One of the theoretical NOESY spectra is illustrated in Fig. 7 ; the experimental NOESY spectrum is shown for comparison in black. The agreement between the theoretical and experimental spectra is generally good. The higher regularity of the helices in the MD structure, discussed in the previous session, is reflected by an additional cross-peak, Ser populated to an extent to generate observable NOEs.
The NMR study of hPTH- in the presence of DPC micelles indicates that indeed the membrane environment can induce a higher degree of conformational order, extending and stabilizing both the N-terminal and C-terminal ␣-helix. If the two helices, and the consequent amphipathic exposure of the amino acids, are relevant elements in the bioactive conformation, the interaction with the cellular membrane could present to the receptor a ligand folded into a preferred conformation (25, 58) . Similar to the results obtained in water and saline solution the two helical domains are separated by a region of flexibility, in this case centered about residues 18 and 19 (i.e. shifted more toward the C terminus than was observed in the other two environments). This allows the two "halves" of the molecule to adopt a range of relative orientations. However, no evidence for helix-helix interaction in a tertiary structure was observed in the presence of DPC. Likewise, we could not find any support for a turn conformation in the connecting loop separating the two helices.
In conclusion, under the experimental conditions examined in this study, the formation of a hydrophobic core between the two amphiphilic helices, resulting in a U-shaped conformation is not detectable either in aqueous solution or in the presence of micelles. A conformation in which the N and C termini of hPTH are in close proximity may indeed be preferred upon binding to the receptor, as suggested by biological activities and receptor binding affinities of chimeric PTH/PTHrP (4). However, our results clearly indicate that, even if the U-shape fold is energetically accessible, the peptide does not assume this conformation in solution. Instead it is possible that the flexibility of the molecule, allowing different relative spatial arrangements of the two helical domains, is a requirement to adopt the proper conformation for interacting with the receptor. Results from a series of lactam containing PTHrP-derived analogs have shown that flexibility around residue 19 is required for high biological activity of these analogs (59) . The PTHrP analog, RS-66271, containing a model amphiphilic ␣-helix, likewise displayed a flexible domain immediately N-terminal of the C-terminal helix (60) . The magnitude of the conformational changes induced by the receptor will only be obtained from analysis of the receptor bound hormone. We are approaching this by photoaffinity cross-linking and mapping out contact points between the hormone and receptor (61) . These investigations, coupled with high resolution structures of the hormone in the different environments that the hormone may experience upon interacting with the receptor, will provide the structural insight required for the rational design of PTH-derived agonists.
